Atlas FDA

Lotus TAVR 27mm, Transcatheter Aortic Valve Prosthesis Premounted on Delivery System; Sterile Material number H749LTV270

FDA device recall Z-0917-2015 · posted 2015-01-13 · Terminated

Recall details

Recalling firm
Boston Scientific Corporation
Reason for recall
Lotus valve became unlocked during release from the delivery system. This may lead to percutaneous insertion of another valve, resulting in a Valve in Valve (ViV) implantation. If this occurs, the first valve could embolize and it may be necessary to convert the patient to surgery.
Action taken
Boston Scientific notified consignees on November 19, 2014, of the problem via letter through overnight delivery directing consignees to segregate and return affected product to Boston Scientific utilizing the Field Safety Corrective Action (FSCA) Instructions provided. The FSCA details that consignees should: Immediately discontinue use of and segregate product; Complete and return the Account Reply Verification Tracking form and Package/Ship the affected product.
Root cause
Device Design
Status
Terminated
Product code
NPT
Quantity affected
278 units - total all sizes
Distribution
Distributed only in the countries of Finland, France, Germany, Great Britain, Italy, Norway, Spain, Sweden, and Switzerland.
Date initiated
2014-11-19
Date posted
2015-01-13
Date terminated
2015-03-26
Location
Los Gatos, CA

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.